OTC:CC - Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
(TheNewswire)
Calgary, Alberta – TheNewswire - September 1, 2023 - Ocumetics Technology Corp.(“ Ocumetics ” or the “ Corporation ”) ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) a pioneer in advanced eyecare solutions, is pleased to announce the appointment of Dr. DoyleStulting and Dr. Bart McRoberts to its Board of Directors. With theirunparalleled expertise in ophthalmology and vision research, Drs.Stulting and McRoberts bring a wealth of knowledge that will helpdrive Ocumetics’ innovation and commitment to improving eye careglobally.
Dr. Robert Doyle Stulting has authored over 250 papersin peer-reviewed journals, published several textbook chapters, taughtcourses for over 30 years at the American Academy of Ophthalmology,and lectured around the world. He was awarded the American Academyof Ophthalmology’s Lifetime Achievement Award and the FDA’sCitation for Excellence, Commitment, and Outstanding Service inProtecting the Public. Dr. Stulting has served as theCorporation’s Chief Medical Officer since October 1, 2021.
Dr. James Barton McRoberts received his Doctorate inOptometry in 1974 from the University of Waterloo. He has managed aprivate clinical practice since 1974 in both Squamish and WestVancouver. Dr. McRoberts brings a vast array of experience toOcumetics. Among other things, he has functioned as the professionalservices director of The Laser Center in Vancouver, the VP and a boardmember of Optometric Services Ltd. Montreal and as the President ofthe British Columbia Association of Optometrists. Dr. McRoberts hasalso served as the Registrar and Deputy Registrar for the College ofOptometrists.
“Dr. Stulting and Dr. McRoberts are renowned figuresin the field of eyecare, and their visionary contributions willundoubtedly propel Ocumetics to new heights,” commented Dr GarthWebb, Chairman of Ocumetics. “Their presence on our board reinforcesour dedication to enhancing visual health and revolutionizing the waywe approach eye care.”
“As Ocumetics continues to push the boundaries of eyecare, the addition of these accomplished professionals solidifies thecompany’s mission to create a brighter, clearer future forindividuals worldwide,” adds Dean Burns, President and CEO ofOcumetics.
About Ocumetics
Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)is a Canadian research and product development company thatspecializes in adaptive lens designs. Ocumetics is in thepreclinical study stage of a game-changing technology for theophthalmic industry. Ocumetics has developed an expandableintraocular lens that fits within the natural lens compartment of theeye potentially to eliminate the need for corrective lenses. It isdesigned to allow the eye’s natural muscle activity to shift focusfrom distance to near.
FOR FURTHER INFORMATION, PLEASECONTACT:
Dean Burns
President and CEO
(817) 874-7564
Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
Copyright (c) 2023 TheNewswire - All rights reserved.